Persistent ocular allergy is part of systemic atopy.
Chronic eye itch, redness and tearing are not just an isolated nuisance — they often reflect underlying type 2 inflammation shared with rhinitis, asthma and atopic dermatitis.
Daily impact
Persistent ocular symptoms disrupt screen work, driving, sleep and social interaction — and frequently mark a wider atopic burden that deserves systemic evaluation.
When to seek specialized evaluation
- Itch, redness or tearing most days despite topical treatment
- Coexisting allergic rhinitis, asthma or atopic dermatitis
- Severe forms (vernal or atopic keratoconjunctivitis)
- Repeated need for ocular corticosteroids
- Impact on sleep, work or quality of life
How we evaluate
We characterize ocular triggers, screen for systemic atopy and type 2 comorbidities, review prior allergy testing, and coordinate with ophthalmology when severe ocular surface disease is suspected.
Advanced treatment options
Beyond topical antihistamines and mast-cell stabilizers, severe phenotypes may benefit from allergen immunotherapy and — when overlapping with severe systemic atopy — from biologic therapies acting on shared type 2 pathways.
Eyes are a window into systemic atopy.
Ocular allergy rarely occurs in isolation. Mapping the full inflammatory pattern often reframes long-term care.
